Uniprot AC	Entrez ID	Gene Name	Disease	Cell Type	PTM Type	State	Position	PMID
P37840	6622	SNCA NACP PARK1	Hepatocellular carcinoma		Phosphorylation	N	S9	
P37840	6622	SNCA NACP PARK1	Lung adenocarcinoma		Phosphorylation	N	S9	
P37840	6622	SNCA NACP PARK1	Hepatocellular carcinoma		SUMOylation	N	K10	
P37840	6622	SNCA NACP PARK1	Lung adenocarcinoma		SUMOylation	N	K10	
P37840	6622	SNCA NACP PARK1	Hepatocellular carcinoma		SUMOylation	N	K12	
P37840	6622	SNCA NACP PARK1	Lung adenocarcinoma		SUMOylation	N	K12	
P37840	6622	SNCA NACP PARK1	Hepatocellular carcinoma		Ubiquitination	N	K12	
P37840	6622	SNCA NACP PARK1	Lung adenocarcinoma		Ubiquitination	N	K12	
P37840	6622	SNCA NACP PARK1	Hepatocellular carcinoma		Acetylation	N	K21	
P37840	6622	SNCA NACP PARK1	Lung adenocarcinoma		Acetylation	N	K21	
P37840	6622	SNCA NACP PARK1	Hepatocellular carcinoma		SUMOylation	N	K21	
P37840	6622	SNCA NACP PARK1	Lung adenocarcinoma		SUMOylation	N	K21	
P37840	6622	SNCA NACP PARK1	Hepatocellular carcinoma		Ubiquitination	N	K21	
P37840	6622	SNCA NACP PARK1	Lung adenocarcinoma		Ubiquitination	N	K21	
P37840	6622	SNCA NACP PARK1	Lung adenocarcinoma		SUMOylation	N	K23	
P37840	6622	SNCA NACP PARK1	Lung adenocarcinoma		Ubiquitination	N	K23	
P37840	6622	SNCA NACP PARK1	Parkinson's disease		Acetylation	N	K32	
P37840	6622	SNCA NACP PARK1	Bladder urothelial carcinoma		SUMOylation	N	K34	
P37840	6622	SNCA NACP PARK1	Parkinson's disease		SUMOylation	N	K34	
P37840	6622	SNCA NACP PARK1	Bladder urothelial carcinoma		Phosphorylation	N	Y39	
P37840	6622	SNCA NACP PARK1	Bladder urothelial carcinoma		Phosphorylation	N	S42	
P37840	6622	SNCA NACP PARK1	Parkinson's disease		Phosphorylation	N	S42	
P37840	6622	SNCA NACP PARK1	Parkinson's disease		Ubiquitination	N	K43	
P37840	6622	SNCA NACP PARK1	Parkinson's disease		Acetylation	N	K58	
P37840	6622	SNCA NACP PARK1	Brain lower grade glioma		O-linked glycosylation	N	T75	
P37840	6622	SNCA NACP PARK1	Lung adenocarcinoma		O-linked glycosylation	N	T75	
P37840	6622	SNCA NACP PARK1	Lung adenocarcinoma		SUMOylation	N	K80	
P37840	6622	SNCA NACP PARK1	Lung adenocarcinoma		O-linked glycosylation	N	T81	
P37840	6622	SNCA NACP PARK1	Stomach adenocarcinoma		O-linked glycosylation	N	S87	
P37840	6622	SNCA NACP PARK1	Stomach adenocarcinoma		Phosphorylation	N	S87	
P37840	6622	SNCA NACP PARK1	Parkinson's disease		Acetylation	N	K96	
P37840	6622	SNCA NACP PARK1	Stomach adenocarcinoma		Acetylation	N	K96	
P37840	6622	SNCA NACP PARK1	Parkinson's disease		SUMOylation	N	K96	
P37840	6622	SNCA NACP PARK1	Stomach adenocarcinoma		SUMOylation	N	K96	
P37840	6622	SNCA NACP PARK1	Parkinson's disease		SUMOylation	N	K102	
P37840	6622	SNCA NACP PARK1	Parkinson's disease		Phosphorylation	N	Y125	
P37840	6622	SNCA NACP PARK1	Parkinson's disease		Phosphorylation	N	S129	
P37840	6622	SNCA NACP PARK1	Uterine cancer		Phosphorylation	N	S129	
P37840	6622	SNCA NACP PARK1	Parkinson's disease		Phosphorylation	N	Y133	
P37840	6622	SNCA NACP PARK1	Skin cutaneous melanoma		Phosphorylation	N	Y133	
P37840	6622	SNCA NACP PARK1	Skin cutaneous melanoma		Phosphorylation	N	Y136	
P37840	6622	SNCA NACP PARK1	Pheochromocytoma	PC12 cell line	Ubiquitination	P		18065497
P37840	6622	SNCA NACP PARK1	Parkinson's disease		Ampylation	D	T33	31034889
P37840	6622	SNCA NACP PARK1	Parkinson's disease		Tyrosine phosphorylation	U	Y39	27348587;28636593;27348587;27348587;28636593;28636593
P37840	6622	SNCA NACP PARK1	Parkinson's disease		Ampylation	D	T54	31034889
P37840	6622	SNCA NACP PARK1	Parkinson's disease		Ampylation	D	T75	31034889
P37840	6622	SNCA NACP PARK1	Huntington's disease		Serine phosphorylation	U	S129	35659303
P37840	6622	SNCA NACP PARK1	Lewy body disease		Tyrosine phosphorylation	U	Y136	34772466
P37840	6622	SNCA NACP PARK1	Parkinson's disease	cell line	SUMOylation	D	K96	21746851
P37840	6622	SNCA NACP PARK1	Parkinson's disease	cell line	SUMOylation	D	K102	21746851
P37840	6622	SNCA NACP PARK1	Parkinson's disease	Keynon cells	Serine phosphorylation	U	S129	21562258;21849493;21865317;11813001;12505616;14579119;24204929;11813001;28636593;14579119;12505616;22344688;21562258;25637461;21865317;21849493;34974168;12505616;11813001;14579119;16847063;21562258;21400129;21865317;22344688;25637461;28636593;34220490;34115198;34658833;32156613;31933723;35659116;36179692;35418851;37667227;22344688;25637461;28636593;24204929
P37840	6622	SNCA NACP PARK1	Synucleinopathy	Keynon cells	Serine phosphorylation	U	S129	12505616;12505616;16847063
P37840	6622	SNCA NACP PARK1	Parkinson's disease		Phosphorylation	P		29737566
P37840	6622	SNCA NACP PARK1	Parkinson's disease		Threonine phosphorylation	P	T64	37252975
P37840	6622	SNCA NACP PARK1	Dementia with Lewy bodies		Serine phosphorylation	D	S129	35353605
P37840	6622	SNCA NACP PARK1	Parkinson's disease		Serine phosphorylation	D	S129	35353605
P37840	6622	SNCA NACP PARK1	Alzheimer's disease		Serine phosphorylation	U	S129	19889641
P37840	6622	SNCA NACP PARK1	Dementia with Lewy bodies		Serine phosphorylation	U	S129	35659116;36847016
P37840	6622	SNCA NACP PARK1	Multiple system atrophy		Serine phosphorylation	U	S129	35659116;36304930
